id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-326807-dii4u9gj	Kow, Chia Siang	Use of low-molecular-weight heparin in COVID-19 patients	2020-06-17		.txt	text/plain	250	24	50	key: cord-326807-dii4u9gj title: Use of low-molecular-weight heparin in COVID-19 patients cord_uid: dii4u9gj [1] in their study reported cases of deep venous thrombosis (DVT) in hospitalised 16 patients with 2019 novel coronavirus disease (COVID-19). We appreciate the efforts by authors 17 to present preliminary data on COVID-19-related DVT in their practicing insitution and discuss 18 the possible underlying mechanism of DVT. According to the authors, administration of anticoagulant doses of low-molecular-weight heparin 20 (LMWH) in hospitalized COVID-19 patients, instead of prophylactic doses, was the current practice in their institution. Higher than traditional, 2 standard prophylactic dose of LMWH as adopted in authors' institution should be encouraged Higher-than-usual rate of thromboprophylaxis failure may be due to an increasingly recognized Upsurge of deep venous thrombosis in patients affected by COVID-4 19: Preliminary data and possible explanations Incidence of venous thromboembolism in 7 hospitalized patients with COVID-19 The procoagulant pattern of patients with COVID-10 19 acute respiratory distress syndrome Hypercoagulability of COVID-19 patients in 13	./cache/cord-326807-dii4u9gj.txt	./txt/cord-326807-dii4u9gj.txt